Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
11.15
-0.66 (-5.59%)
At close: Aug 1, 2025, 4:00 PM
11.24
+0.09 (0.81%)
After-hours: Aug 1, 2025, 4:33 PM EDT
Lyell Immunopharma Stock Forecast
Stock Price Forecast
The 2 analysts that cover Lyell Immunopharma stock have a consensus rating of "Sell" and an average price target of $15, which forecasts a 34.53% increase in the stock price over the next year. The lowest target is $10 and the highest is $20.
Price Target: $15.00 (+34.53%)
Analyst Consensus: Sell
* Price targets were last updated on Jun 24, 2025.
Analyst Ratings
The average analyst rating for Lyell Immunopharma stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $1 → $10 | Hold | Maintains | $1 → $10 | -10.31% | Jun 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +79.37% | Apr 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +79.37% | Mar 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +79.37% | Nov 12, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $120 → $20 | Strong Buy → Sell | Downgrades | $120 → $20 | +79.37% | Oct 30, 2024 |
Financial Forecast
Revenue This Year
8.67K
from 61.00K
Decreased by -85.79%
Revenue Next Year
n/a
from 8.67K
EPS This Year
-15.77
from -26.23
EPS Next Year
-14.85
from -15.77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 10,500 | n/a | 64,050 |
| Avg | 8,670 | n/a | 31,110 |
| Low | 6,860 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -82.8% | - | - |
| Avg | -85.8% | - | - |
| Low | -88.8% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -15.39 | -13.49 | -6.97 |
| Avg | -15.77 | -14.85 | -6.77 |
| Low | -15.93 | -15.24 | -6.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.